Envista Holdings Shares Outstanding 2018-2026 | NVST

Envista Holdings shares outstanding from 2018 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Envista Holdings Annual Shares Outstanding
(Millions of Shares)
2025 169
2024 172
2023 167
2022 178
2021 178
2020 164
2019 136
2018 128
2017 128
Envista Holdings Quarterly Shares Outstanding
(Millions of Shares)
2026-03-31 166
2025-12-31 166
2025-09-30 166
2025-06-30 170
2025-03-31 174
2024-12-31 172
2024-09-30 173
2024-06-30 172
2024-03-31 173
2023-12-31 167
2023-09-30 175
2023-06-30 176
2023-03-31 177
2022-12-31 178
2022-09-30 177
2022-06-30 179
2022-03-31 180
2021-12-31 178
2021-09-30 178
2021-06-30 178
2021-03-31 176
2020-12-31 164
2020-09-30 164
2020-06-30 160
2020-03-31 159
2019-12-31 136
2019-09-30 131
2019-06-30 128
2019-03-31 128
2018-12-31
2018-09-30 128
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.301B $2.720B
Envista Holdings Corporation manufactures and sells dental products primarily in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics and dental eye loupes to oral surgeons, prosthodontists and periodontists; Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. Envista Holdings Corporation is based in Brea, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $174.688B 19.48
Stryker (SYK) United States $129.889B 24.88
Medtronic (MDT) Ireland $111.968B 15.57
EssilorLuxottica (ESLOY) France $107.724B 0.00
Boston Scientific (BSX) United States $91.831B 20.26
Medline (MDLN) United States $59.904B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.712B 0.00
GE HealthCare Technologies (GEHC) United States $33.391B 15.98
ResMed (RMD) United States $33.341B 22.26
Agilent Technologies (A) United States $32.516B 20.44
Koninklijke Philips (PHG) Netherlands $27.260B 16.18
Terumo (TRUMY) Japan $19.854B 23.21
Zimmer Biomet Holdings (ZBH) United States $18.025B 11.36
Smith & Nephew SNATS (SNN) United Kingdom $14.227B 0.00
Insulet (PODD) United States $13.640B 39.54
Baxter (BAX) United States $8.854B 7.56
Sunny Optical Technology (SNPTF) China $8.381B 0.00
Bio-Rad Laboratories (BIO) United States $7.537B 28.15
Demant (WILYY) Denmark $6.395B 0.00
Lantheus Holdings (LNTH) United States $5.247B 15.90
BillionToOne (BLLN) United States $3.729B 0.00
DiaSorin S.p.A (DSRLF) Italy $3.666B 0.00
ICU Medical (ICUI) United States $3.141B 20.47
Prestige Consumer Healthcare (PBH) United States $2.676B 12.62
Haemonetics (HAE) United States $2.664B 11.65
LeMaitre Vascular (LMAT) United States $2.611B 48.16
Phibro Animal Health (PAHC) United States $2.347B 20.67
GN Store Nord (GNNDY) Denmark $2.270B 21.90
Neogen (NEOG) United States $2.050B 44.86
Shandong Weigao Medical Polymer (SHWGF) China $2.028B 0.00
Capricor Therapeutics (CAPR) United States $1.794B 0.00
AdaptHealth (AHCO) United States $1.654B 32.89
Curaleaf Holdings (CURLF) Canada $1.584B 0.00
Perrigo (PRGO) Ireland $1.495B 3.96
AtriCure (ATRC) United States $1.429B 0.00
Green Thumb Industries (GTBIF) United States $1.386B 15.91
Kestra Medical Technologies (KMTS) United States $1.043B 0.00
BioLife Solutions (BLFS) United States $0.953B 164.50
QuidelOrtho (QDEL) United States $0.943B 6.53
Lumexa Imaging Holdings (LMRI) United States $0.896B 0.00
InMode (INMD) Israel $0.857B 9.40
Omeros (OMER) United States $0.827B 6.49
Maravai LifeSciences Holdings (MRVI) United States $0.789B 0.00
Tilray Brands (TLRY) Canada $0.766B 0.00
CeriBell (CBLL) United States $0.683B 0.00
Brainsway (BWAY) Israel $0.546B 55.68
Valneva SE (VALN) France $0.532B 0.00
VAREX IMAGING (VREX) United States $0.468B 11.18
Cresco Labs (CRLBF) United States $0.458B 0.00
Canopy Growth (CGC) Canada $0.424B 0.00
Verano Holdings (VRNO) United States $0.415B 0.00
Viemed Healthcare (VMD) United States $0.367B 25.70
SNDL (SNDL) Canada $0.366B 0.00
Cerus (CERS) United States $0.363B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.311B 126.00
Evolus (EOLS) United States $0.278B 0.00
TriSalus Life Sciences (TLSI) United States $0.259B 0.00
MacroGenics (MGNX) United States $0.229B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
Accendra Health (ACH) United States $0.215B 2.96
Utah Medical Products (UTMD) United States $0.210B 18.94
High Tide (HITI) Canada $0.205B 0.00
OraSure Technologies (OSUR) United States $0.205B 0.00
Aurora Cannabis (ACB) Canada $0.194B 57.17
TerrAscend (TSNDF) Canada $0.193B 0.00
Organigram Global (OGI) Canada $0.191B 0.00
Apyx Medical (APYX) United States $0.166B 0.00
Quanterix (QTRX) United States $0.158B 0.00
Quipt Home Medical (QIPT) United States $0.157B 0.00
Sanara MedTech (SMTI) United States $0.152B 0.00
Sanuwave Health (SNWV) United States $0.145B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.143B 0.00
Vireo Growth (VREOF) United States $0.133B 0.00
Fonar (FONR) United States $0.115B 16.53
Jushi Holdings (JUSHF) United States $0.101B 0.00
FitLife Brands (FTLF) United States $0.090B 11.73
Exagen (XGN) United States $0.073B 0.00
Sharps Technology (STSS) United States $0.065B 0.00
ImmuCell (ICCC) United States $0.064B 0.00
Biote (BTMD) United States $0.063B 3.46
INLIF (INLF) China $0.053B 0.00
Cytosorbents (CTSO) United States $0.038B 0.00
Veru (VERU) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.036B 0.00
Nephros (NEPH) United States $0.032B 26.91
United-Guardian (UG) United States $0.030B 14.23
Bonk (BNKK) United States $0.021B 0.00
Jin Medical (ZJYL) China $0.018B 0.00
Modular Medical (MODD) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Flora Growth (FLGC) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Agape ATP (ATPC) $0.003B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
IM Cannabis (IMCC) Canada $0.002B 0.00
Akanda (AKAN) Canada $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00